John Rinker II

John Rinker II
Associate Professor

Associate Professor (P), Neurology , School of Medicine
Associate Scientist (C), Center for Clinical and Translational Science (CCTS) , General Clinical Research Center
Scientist (C), Comprehensive Neuroscience Center , General Clinical Research Center
Scientist (C), Multiple Sclerosis Center , Neurology

Selected Publications

Academic Article

Year	Title	Altmetric
2023	Feasibility and acceptability of time-restricted eating in a group of adults with multiple sclerosis. Frontiers in Neurology. 13. 2023
2021	The Importance and Opportunity for Healthy Aging Through Lifestyle, Behavior Medicine Among Older Adults With Multiple Sclerosis: the Case Based on Physical Activity. Current Treatment Options in Neurology. 23. 2021
2021	Neurology Electives: A Neurologist’s Guide for Excelling During Medical Student Away Rotations. Frontiers in Education. 6. 2021
2020	Feasibility of improving dietary quality using a telehealth lifestyle intervention for adults with multiple sclerosis. Multiple Sclerosis and Related Disorders. 46. 2020
2020	Randomized feasibility trial to assess tolerance and clinical effects of lithium in progressive multiple sclerosis. Vaccine Reports. 6. 2020
2020	The Future of Progressive Multiple Sclerosis Therapies.. Federal practitioner : for the health care professionals of the VA, DoD, and PHS. 37:S43-S49. 2020
2019	Protocol for a systematically-developed, phase I/II, single-blind randomized controlled trial of treadmill walking exercise training effects on cognition and brain function in persons with multiple sclerosis. Contemporary Clinical Trials. 87. 2019
2018	Rationale and design of a single-blind, randomised controlled trial of exercise training for managing learning and memory impairment in persons with multiple sclerosis. BMJ Open. 8. 2018
2017	Effect of Template Reporting of Brain MRIs for Multiple Sclerosis on Report Thoroughness and Neurologist-Rated Quality: Results of a Prospective Quality Improvement Project. Journal of the American College of Radiology. 14:371-379.e1. 2017
2016	Symptomatic management of multiple sclerosis-associated tremor among participants in the NARCOMS registry. International Journal of MS Care. 18:147-153. 2016
2015	Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: A cross-sectional survey. BMJ Open. 5. 2015
2014	Improvement of multiple sclerosis-associated tremor as a treatment effect of natalizumab. Multiple Sclerosis and Related Disorders. 3:505-512. 2014
2013	A retrospective review of lithium usage in veterans with multiple sclerosis. Multiple Sclerosis and Related Disorders. 2:327-333. 2013
2011	Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis. JAMA Neurology. 68:437-444. 2011
2010	Neurocognitive sequelae in African American and Caucasian children with multiple sclerosis. Neurology. 75:2097-2102. 2010
2009	Candidate gene analysis of selectin cluster in patients with multiple sclerosis. Journal of Neurology. 256:832-833. 2009
2008	Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation 2008
2007	Diagnosis and differential diagnosis of multiple sclerosis. CONTINUUM: Lifelong Learning in Neurology. 13:13-34. 2007
2007	Higher IgG index found in African Americans versus Caucasians with multiple sclerosis. Neurology. 69:68-72. 2007
2006	Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis. Neurology. 67:1288-1290. 2006

Chapter

Year	Title	Altmetric
2017	Deimination in multiple sclerosis: The bad, the good, and the ugly. 317-336. 2017
2017	Women and neurological disability: End-of-life care and mortality in women with MS. 113-126. 2017
2006	Multiple sclerosis: An autoimmune disease of the central nervous system?. 95-112. 2006